Actavis may buy Allergan for at least $60 billion: Bloomberg

Actavis may buy Allergan for at least $60 billion: Bloomberg

(Reuters) – Merger talks between Allergan Inc and white knight Actavis Plc are focused on narrowing a gap of about $3 billion between what has been offered and what is wanted, Bloomberg reported on Wednesday. Actavis is willing to pay around $200 per …

7
Like
Save

Comments

Write a comment

*